Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Resumen: Introduction: Anxiety and depression are the most common psychological symptoms in patients with cancer, irrespective of disease stage, primary cancer site and phase of treatment. Symptoms may range from nonpathological states, such as concerns, worry, sense of uncertainty, sadness and increased levels of hopelessness, to specific psychiatric syndromes (i.e. anxiety and depressive disorders). The latter are associated with significant distress and marked disability, poor quality of life (QoL), increased physical symptoms (e.g. pain or nausea), poor adherence to treatment, increased risk of suicide (in people with depression), poorer prognosis and higher mortality.1, 2, 3, 4 It is important for clinicians to understand the difference between nonpathological fluctuations in anxious or depressive states, which are not intense and are short-lived emotional responses to life challenges, and the more specific and impactful psychopathological conditions, such as anxiety and/or depressive disorders. There is a spectrum of highly comorbid syndromes which can be categorised by the criteria of the World Health Organization International Classification of Diseases (ICD), 11th edition (updated chapter on ‘Mental, behavioural or neurodevelopmental disorders’)5 and the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM), fifth edition-Text Revision (DSM-5-TR)...
Idioma: Inglés
DOI: 10.1016/j.esmoop.2023.101155
Año: 2023
Publicado en: ESMO Open 8, 2 (2023), 101155 [14 pp.]
ISSN: 2059-7029

Factor impacto JCR: 7.1 (2023)
Categ. JCR: ONCOLOGY rank: 40 / 322 = 0.124 (2023) - Q1 - T1
Factor impacto CITESCORE: 11.7 - Cancer Research (Q1) - Oncology (Q1)

Factor impacto SCIMAGO: 2.498 - Oncology (Q1) - Cancer Research (Q1)

Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Area Psiquiatría (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.


Exportado de SIDERAL (2024-07-31-09:56:35)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2023-05-25, última modificación el 2024-07-31


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)